Exscientia
ignite phase initiated in | Exscientia
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
30 of 73
Similar slides by Exscientia
See diffirences between slides (animation)
Investor Presentation
August 2023
ignite phase initiated in | Exscientia
Related slides by other companies
Nuvalent
Investor Presentation
January 2024
for her a brain penetrant her selective inhibitor with to minimize related adverse events activity against mutations and the potential i | Nuvalent
Nuvalent
Investor Presentation
February 2024
pipeline advancing a portfolio of potentially best in class products with complementary initial indications in lead indication product candidate discovery enabling phase phase anticipated milestones rights open enrolling phase portion phase trial data update medical meeting alk open enrolling phase portion phase trial phase initiation data update medical meeting her phase initiation undisclosed targets additional discovery research programs ongoing key milestone achieved planned milestone | Nuvalent
MAIA Biotechnology
Investor Presentation
July 2023
robust pipeline thio thio thio first line | MAIA Biotechnology
BioAtla
Investor Presentation
January 2024
cab phase dose titration ongoing | BioAtla
Other recent decks by Exscientia
See all presentations (14 decks)
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights